Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02246309 · ClinicalTrials.gov registry record · NA
Comparison Of The Embryoscope Time-Lapse System With Standard Embryo Culture
A NA study, sponsored by Center for Human Reproduction.
- Terminated
- Registry status
- NA
- Development phase
- 31
- Enrollment target
NCT02246309: Clinical Trial NA study, sponsored by Center for Human Reproduction.
NCT02246309 is a NA study that was terminated before completion, run by Center for Human Reproduction. The registered enrollment target is 31 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02246309, a NA study, was terminated before completion, sponsored by Center for Human Reproduction.
- TERMINATED
- Registry status
- NA
- Development phase
- 31 participants
- Enrollment target
Study Summary
"Embryoscopes," allow for embryo culture to be performed in an automated incubation system under time lapse photography. Manufacturers of these systems (and investigators who have used these systems) claim that the availability of 24-hour time-lapse photographic control improves embryo selection and, therefore, IVF (in vtro fertilization) pregnancy rates. They also claim that use of this system saves laboratory personnel time. This study will randomize approximately 120 patients (60 in each arm) to standard embryo culture or to culture in an Embryoscope. The primary endpoint will be a comparison of time spent by the laboratory personnel with each system. Secondary endpoints will be IVF outcomes.
Primary Outcome
Number of minutes spent by laboratory personnel technical staff in support of each system
Interventions
- DEVICE Embryoscope Time Lapse System
- DEVICE Standard Embryo Culture
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 31 participants |
| Start Date | 2014-09 |
| Est. Completion | 2015-12 |
| Phase | NA |
Why NCT02246309 stopped before completion
NCT02246309 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 31 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 2 interventions - of which Embryoscope Time Lapse System is the first listed.
NCT02246309 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02246309 about?
NCT02246309 is a clinical study titled "Comparison Of The Embryoscope Time-Lapse System With Standard Embryo Culture". "Embryoscopes," allow for embryo culture to be performed in an automated incubation system under time lapse photography. Manufacturers of these systems (and investigators who have used these systems) claim that the availability of 24-hour time-lapse photographic control improves embryo selection and...
What is the current status of trial NCT02246309?
This trial is currently terminated. It is a NA study. The enrollment target is 31 participants. The study started on 2014-09. Estimated completion is 2015-12.
What interventions are being tested in trial NCT02246309?
The interventions under investigation include: Embryoscope Time Lapse System (DEVICE), Standard Embryo Culture (DEVICE).
Who is sponsoring clinical trial NCT02246309?
This trial is sponsored by Center for Human Reproduction, which has 8 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02246309's enrollment target sits among peer trials
31 1592nd of 2000 higher than 408 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02932618 · 31 participants · Phase 3
A Study of Recombinant Von Willebrand Factor (rVWF) With or Without ADVATE in Children With Severe Von Willebrand Disease (VWD)
- NCT03482297 · 31 participants · Phase 1
Automated Abdominal Binder for Orthostatic Hypotension
- NCT04016389 · 31 participants · NA
FIGO 2018 Stage IB2 Cervical Cancer Treated With Neoadjuvant Chemotherapy Followed by Fertility Sparing Surgery
- NCT04211675 · 31 participants · Phase 1
NK Cells Infusions With Irinotecan, Temozolomide, and Dinutuximab
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia